"Billionaire" and "successful hedge fund manager" are titles that carry significant weight on Wall Street. These and others ...

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

Patients who took the higher dose of Innovent’s mazdutide for 48 weeks lost nearly 15% of their body weight in a study of more than 610 Chinese people who were either overweight or obese ...

Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.

We recently published detailed insights on two next-generation GLP-1 medications, providing valuable information for individuals seeking the latest updates in the field: Mazdutide: A Next-Gen GLP ...